Roswell Park Comprehensive Cancer Center was chosen by the National Cancer Institute to serve as a Lead Academic Participating Site, providing scientific leadership for the development and conduct of clinical trials within the NCI’s new National Clinical Trials Network. The NCTN was created to speed the late-phase clinical trials that are necessary to establish new therapeutic agents as cancer treatments for the 1.6 million Americans diagnosed with cancer each year.

Six projects that seek new ways to harness the immune system in order to prolong the survival of women with ovarian cancer received project funding from a landmark grant jointly held by Roswell Park Comprehensive Cancer Center and the University of Pittsburgh Cancer Institute.

Dozens of Roswell Park Comprehensive Cancer Center physicians and scientists will be among those gathering in Chicago this weekend as the American Society of Clinical Oncology (ASCO), the world’s largest association of oncologists, marks an important milestone — ASCO’s 50th Annual Meeting.

BUFFALO, NY — Martin Brecher, MD, who began treating pediatric cancer patients at Roswell Park Comprehensive Cancer Center in 1975 and since became Chairman of Pediatrics for Roswell Park as well as Chief, Division of Pediatr

BUFFALO, N.Y. — Ball placement. Suture pass. Needle handle and exchange. These are terms you’ll typically hear only in conversations involving surgical staff or medical students.